A $2 trillion coronavirus stimulus package that aims to provide economic relief amid the pandemic is expected to be passed by the House today and signed into law by President Donald Trump. The package contains provisions related to medical devices and drugs, including provisions that would create an over-the-counter drug user fee system and grant exclusivity for certain OTC medicines.
An additional $10 million will be donated by Medtronic's foundation to COVID-19 relief efforts worldwide. The donation will be used to support and ensure the safety of frontline health care personnel and comes after the company pledged had already pledged $1.2 million last month.
As the novel coronavirus pandemic continues to pummel countries and challenge the health care ecosystem, the FDA is taking decisive steps to make it easier for life sciences companies to help combat the crisis.
Navigation apps such as Waze are collecting an abundance of data, which makes them a viable tool for marketers in boosting sales via location-specific ads, says Barbara Kahn, Wharton marketing professor. In this interview, Kahn discusses the value of navigation apps for driving retail sales and successful campaigns, and notes a key to success is "thinking about how you interact with the customer around the shopping experience."
The FDA's clinical study report pilot program, which was meant to increase transparency in the drug approval process, has been officially ended. The agency said it is working on a new way of disclosing study reports.
The FDA has given Thermo Fisher Scientific's COVID-19 test expanded emergency use authorization and European regulators have also given the test CE mark approval.
European regulators have given CE mark approval to CardioQuip for its MCH-1000 Modular Cooler-Heater series. The device is used to control the temperature of a patient during surgery and could help in the treatment of patients with the novel coronavirus.
Fosun Long March Medical Science, a subsidiary of Fosun Pharmaceutical, was granted emergency approval for its SARS-CoV-2 detection kit by China's National Medical Products Administration. The kit is able to process 96 samples in two hours.
When COVID-19 first began spreading widely, Aperiomics CEO Crystal Icenhour assumed large biotech firms would meet the demand for tests, but the firm has the equipment, experience, and staff to fill the void and produced one of its own. Aperiomics has begun processing clinical samples for Virginia's public health lab, is working with another lab to handle overflow testing, and is negotiating with a local research institute to provide equipment or staff.
Basic Health International has temporarily switched focus from preventing cervical cancer to preventing the spread of COVID-19 and is raising funds for validation of a rapid, inexpensive COVID-19 test by Atila Biosystems. The test is based on Atila's existing human papillomavirus test platform and doesn't require an RNA test reagent, says Basic Health International founder and president Miriam Cremer.
- Page 1